NVO
Novo Nordisk A/S
NVO trails on the overall score without a compensating advantage in the available component scores.
SHOP
Shopify Inc.
SHOP has the edge over NVO overall, supported by stronger fundamentals and stronger valuation.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SHOP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
SHOP's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO has the edge over SHOP in the historical PE scenario, which offers more potential upside but is not a forecast.
SHOP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 67x | $147 | — |
| Cheap | 78x | $129 | -12% |
| Current | 89x | $147 | — |
| Fair | 107x | $177 | +21% |
| Expensive | 338x | $557 | +280% |
Historical ranges are pointers, not guarantees.
SHOP's PE is in its cheap range at 89x. If earnings grow as analysts expect, today's price would be 67x next year's earnings.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
SHOP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| Low |
SHOP has the edge over NVO on the outlook, with more favorable earnings and profitability expectations.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over SHOP on earnings, with more consistent year-over-year improvement.
SHOP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.20 | +33% |
| Q3 2026 | $1.65 | +21% |
| Q2 2026 | $1.49 | -17% |
| Q1 2026 | $1.02 | -18% |
| Q4 2025 | $0.94 | -40% |
| Q3 2025 | $1.36 | +27% |
| Q2 2025 | $1.80 | +84% |
| Q1 2025 | $1.24 | +$1.41 |
| Q4 2024 | $1.56 | +1633% |
SHOP's earnings per share have fallen from their peak: $1.65 over the past year, against $2.68 in late 2021.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over SHOP on profitability, with a higher operating margin.
SHOP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +32% |
| Q2 2026 | $3.6B | +34% |
| Q1 2026 | $3.2B | +34% |
| Q4 2025 | $3.7B | +31% |
| Q3 2025 | $2.8B | +32% |
| Q2 2025 | $2.7B | +31% |
| Q1 2025 | $2.4B | +27% |
| Q4 2024 | $2.8B | +31% |
SHOP has the edge over NVO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +3.1 points |
| Q2 2026 | 14% | +2.8 points |
| Q1 2026 | 12% | +3.5 points |
| Q4 2025 | 17% | +0.6 points |
| Q3 2025 | 12% | -1 points |
| Q2 2025 | 11% | -0.9 points |
| Q1 2025 | 8.6% | +4 points |
| Q4 2024 | 17% | +3.1 points |
SHOP's operating margin was 15% last quarter, up 3.1 points from the same quarter a year ago.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
SHOP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $816M | +61% |
| Q2 2026 | $654M | +55% |
| Q1 2026 | $476M | +31% |
| Q4 2025 | $715M | +17% |
| Q3 2025 | $507M | +20% |
| Q2 2025 | $422M | +27% |
| Q1 2025 | $363M | +56% |
| Q4 2024 | $611M | +37% |
SHOP has the edge over NVO on cash flow, with more consistent year-over-year improvement.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
SHOP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
SHOP has the edge over NVO on leverage, with a lower net debt burden relative to earnings.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
SHOP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.4 | Neutral |
| Stochastic | 51.5 | Neutral |
SHOP's weekly RSI is 52 (neutral) and its Stochastic is 52 (neutral).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO has the edge over SHOP on valuation relative to its sector.
SHOP PE vs Technology Sector
| Metric | SHOP | Sector median | Relative |
|---|---|---|---|
| PE | 89x | 28x | 219% above |
| PE % | 29 | 35 | 6 pts below |
SHOP is trading at 89x earnings, a 219% premium to the Technology sector's median of 28x.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 50% below its 200-week average.
SHOP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $157.0 | 6.5% below |
| 20 week MA | $143.1 | 2.5% above |
| 50 week MA | $134.4 | 9.2% above |
| 100 week MA | $128.1 | 15% above |
| 200 week MA | $97.7 | 50% above |
SHOP has the edge over NVO on trend strength, trading above more of its moving averages.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has finished higher in four of the last six years, two of them by more than 50%. It's down 22% so far in 2026.
SHOP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.8 | $122.6 | +200% |
| 2021 | $122.6 | $143.9 | +17% |
| 2022 | $143.9 | $33.7 | -77% |
| 2023 | $33.7 | $77.9 | +131% |
| 2024 | $77.9 | $108.2 | +39% |
| 2025 | $108.2 | $170.8 | +58% |
| 2026 YTD | $170.8 | $146.8 | -14% |
SHOP has the edge over NVO on returns for 2026, with the stronger performance.